Join to View Full Profile
4801 Alberta AveEl Paso, TX 79905
Phone+1 915-545-6618
Fax+1 915-215-5386
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard McCallum, MD is a gastroenterologist in El Paso, Texas. He is currently licensed to practice medicine in Texas, Kansas, and Virginia.
Education & Training
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1972 - 1974
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
The University of Queensland Medical SchoolClass of 1968
Certifications & Licensure
KS State Medical License 1996 - 2025
TX State Medical License 2014 - 2025
VA State Medical License 1985 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 4 citationsThe Assessment of Gastrointestinal Transit by the Atmo Capsule: A Comparison With the SmartPill Capsule.Braden Kuo, Allen A Lee, Thomas Abell, Ashok Attaluri, Michael Cline
Clinical Gastroenterology and Hepatology. 2025-08-01 - 7 citationsMetoclopramide Nasal Spray in Women With Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Richard W McCallum, Henry P Parkman, Ronnie Fass, Bal R Bhandari, Marilyn R Carlson
Clinical Gastroenterology and Hepatology. 2024-12-01 - MoPill a novel gastrointestinal positioning system (GPS): New technology to navigate the alimentary tract highway.Irene Sarosiek, Karina Espino, Anthony Lembo, Richard W McCallum
Neurogastroenterology and Motility. 2024-09-01
Press Mentions
Texas Tech Health El Paso to Pioneer Pediatric Research for Borderplex FamiliesJanuary 14th, 2025- Texas Tech Researchers Investigate Effectiveness of ‘GPS for the Digestive Highway’September 12th, 2024
- A GPS for the Gastrointestinal SystemSeptember 11th, 2024
- Join now to see all
Grant Support
- A multicenter, double-blind, randomized, placebo- controlled, parallel study to assess the efficacy of 5- HT4 agonist prucalopride for the treatment of diabetic and idiopathic gastroparesisTEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER AT EL PASO2008–2027
